All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.

The MPN Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your MPN Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The MPN Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the MPN Hub cannot guarantee the accuracy of translated content. The MPN Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
2020-02-11T16:52:17.000Z

An introduction to the MPN Hub

Feb 11, 2020
Share:

Bookmark this article

The MPN Hub were pleased to speak to Jean-Jacques Kiladjian, University of Paris, Paris, FR, during the 61st American Society of Hematology (ASH) meeting in Orlando, US. In this video, Professor Kiladjian provides an introduction to the MPN Hub.

Professor Kiladjian proudly gives an introduction to the MPN Hub, which will be an open-access and unbiased educational websites for all healthcare professionals. Jean-Jacques Kiladjian explains that the MPN Hub will be providing the latest medical information, live congress coverage, trial updates, drug approvals, case studies as well as expert opinions.

An introduction to the MPN Hub

Newsletter

Subscribe to get the best content related to MPN delivered to your inbox